Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | -26.27% | -8.52% | +221.37% |
04/06 | Maia Biotechnology Reveals New Clinical Data Showing Thio?s Strong Efficacy in Non-Small Cell Lung Cancer | CI |
21/05 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Vlad Vitoc
CEO | Chief Executive Officer | 54 | 03/18/03 |
Director of Finance/CFO | 49 | 01/23/01 | |
Sergei Gryaznov
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 01/20/01 | |
Ramiro Guerrero
BRD | Director/Board Member | 59 | - |
Steven Chaouki
BRD | Director/Board Member | 51 | 28/21/28 |
Vlad Vitoc
CEO | Chief Executive Officer | 54 | 03/18/03 |
Cristian Luput
BRD | Director/Board Member | 49 | 01/19/01 |
Stan Smith
BRD | Director/Board Member | 77 | - |
Director/Board Member | 57 | 17/23/17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,837,149 | 17,936,419 ( 82.14 %) | 0 | 82.14 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+221.37% | 82.11M | |
+46.19% | 55.7B | |
+40.26% | 39.91B | |
-6.14% | 39.57B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
+28.38% | 12.17B | |
+24.18% | 12.12B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- MAIA Stock
- Company MAIA Biotechnology, Inc.